Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal High-Flow Oxygen in ILD Pulmonary Rehabilitation
NCT03287713Unknown
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2018
- Primary completion
- Jan 2021
- Modality
- Inhalation Devices
01
Overview
Randomised, open-label trial of oxygen in interstitial lung disease (ILD) (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Oxygen Saturation at 8 weeks. Status: unknown.
02
Drugs
oxygen
03
Conditions
interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT03287713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03287713.